JENNIFER THANKACHAN: Open Payments
NPI 1003599374 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,236 in 29 payments from 11 companies in 2025. Trend: 2023 $536 · 2024 $1,250 · 2025 $1,236
Food & beverage: $1,236
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $348 |
| AstraZeneca Pharmaceuticals LP | 3 | $190 |
| Incyte Corporation | 3 | $162 |
| Syndax Pharmaceuticals, Inc. | 4 | $131 |
| SOBI, INC | 3 | $95 |
| Novartis Pharmaceuticals Corporation | 3 | $91 |
| GlaxoSmithKline, LLC. | 3 | $80 |
| Lilly USA, LLC | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| PharmaEssentia USA Corporation | 1 | $27 |
Products named: IMBRUVICA, CALQUENCE, Jakafi, Vonjo, SCEMBLIX, OJJAARA, EPKINLY, JAYPIRCA.
Industry payments across TX — which companies pay providers there.
